These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 6437952)
1. [In-vitro activity of new beta-lactam antibiotics. Testing resistant enterobacteria and pseudomonas aeruginosa strains]. Rosenthal E Fortschr Med; 1984 Nov; 102(41):1051-2. PubMed ID: 6437952 [TBL] [Abstract][Full Text] [Related]
2. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species]. Schröter G; Schrettenbrunner A; Strenzel I Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236 [TBL] [Abstract][Full Text] [Related]
3. [Activity of new beta-lactam antibiotics]. Cullmann W; Stieglitz M Fortschr Med; 1982 May; 100(19):888-92. PubMed ID: 6807788 [TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of Pseudomonas aeruginosa to aztreonam in comparison to other pseudomonas-active beta-lactam antibiotics and gentamicin]. Wundt W; Lange KP; Baumgärtner M Arzneimittelforschung; 1985; 35(8):1322-5. PubMed ID: 3935123 [TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa. Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625 [TBL] [Abstract][Full Text] [Related]
6. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ]. Thabaut A; Durosoir JL; Meyran M Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006 [TBL] [Abstract][Full Text] [Related]
7. [Sensitivity to antibiotics of Pseudomonas aeruginosa isolated from patients in the years 1986-1988]. Gościniak G; Dolna I; Ruczkowska J; Fleischer M Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1028-32. PubMed ID: 2517806 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa. Patzer J; Gieburowska R; Dzierzanowska D Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544 [TBL] [Abstract][Full Text] [Related]
9. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)]. Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group. Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641 [TBL] [Abstract][Full Text] [Related]
11. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa]. Cluzel M; Chanal M; Sirot J; Cluzel R Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance]. Bert F; Briaud I; Branger C; Lambert-Zechovsky N Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa. Høiby N; Bremmelgaard A; Schouenborg P Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882 [TBL] [Abstract][Full Text] [Related]
14. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae. Thabaut A; Durosoir JL; Saliou P J Antimicrob Chemother; 1981 Sep; 8 Suppl B():123-5. PubMed ID: 19810174 [TBL] [Abstract][Full Text] [Related]
16. Simple method to determine beta-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test. Vedel G J Antimicrob Chemother; 2005 Oct; 56(4):657-64. PubMed ID: 16144872 [TBL] [Abstract][Full Text] [Related]
17. Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents. Davidson S; Lipshitz M; Bogokowski B; Rubinstein E Isr J Med Sci; 1982 Aug; 18(8):859-62. PubMed ID: 6811501 [TBL] [Abstract][Full Text] [Related]
18. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. Ciofu O; Giwercman B; Pedersen SS; Høiby N APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270 [TBL] [Abstract][Full Text] [Related]
19. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics. Burgess DS; Frei CR J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664 [TBL] [Abstract][Full Text] [Related]
20. Effect of beta-lactam antibiotics on the in vitro development of resistance in Pseudomonas aeruginosa. Carsenti-Etesse H; Cavallo JD; Roger PM; Ziha-Zarifi I; Plesiat P; Garrabe E; Dellamonica P Chirurgia (Bucur); 2002; 97(2):151-9. PubMed ID: 12731225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]